Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
10 Patents
#105 in South San Francisco, CA
#7,114 in California
#29,866 in US
#56,047 in the World
Emerald Therapeutics, Inc.
Forward Citations = 15
13 inventors:
South San Francisco, CA, United States of America
Emerald Therapeutics, Inc.
% Expired Patents = 10.0
EPO Patents = 2
Forward Citations = 15
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Daniel J Kleinbaum (10 out of 13 patents)
Brian M Frezza (8 out of 11 patents)
George W Fraser (6 out of 9 patents)
4. Jonathan K Leung (6 out of 9 patents)
5. Brad Bond (5 out of 5 patents)
6. Bradley M Bond (2 out of 5 patents)
7. Courtney E Webster (2 out of 5 patents)
8. Alex M Yoshikawa (1 out of 4 patents)
9. Catherine L Hofler (1 out of 4 patents)
10. Shayna L Hilburg (1 out of 4 patents)
11. Collin A Melton (1 out of 3 patents)
12. Eric Shyr (1 out of 1 patent)
13. Kyla N Velaer (1 out of 1 patent)
10 patents:
Company Overview
Emerald Therapeutics, Inc. is a biotechnology company based in South San Francisco, California, focused on advancing the field of gene therapy. The organization specializes in developing innovative solutions for genetic disorders through its proprietary platform that enables precise and efficient gene editing. By leveraging cutting-edge technologies, Emerald Therapeutics aims to address unmet medical needs and improve patient outcomes in various therapeutic areas, including rare diseases and other genetic conditions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emerald Therapeutics, Inc.. Retrieved from https://idiyas.com/company/emerald-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]